What was Urban's revenue in Q4 FY26?

Urban reported revenue of ₹2,004 Cr in Q4 FY26, a +43% change year-over-year.

Did Urban management deliver on previous promises?

Scorecard data is being built as historical quarters are processed.

Urban Q4 FY26 Research Workspace: Revenue ₹2,004 Cr (+43%)

Q: What guidance did Urban management give?

Consolidated adjusted EBITDA breakeven by Q3 FY28: Management reaffirmed target of achieving consolidated adjusted EBITDA breakeven by Q3 FY28.

Revenue ₹2,004 Cr +43%

EBITDA —

PAT ₹-114 Cr

EBITDA Margin 23%

Duration 63 min

Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Urban Company delivered a standout Q4 FY26, with consolidated NTV surging 42% YoY to ₹1,148 crore and revenue up 43% to ₹426 crore. The India core services business accelerated to 26% NTV growth—the fastest in 11 quarters—driven by densification and the 'faster, cheaper, better' flywheel, with adjusted EBITDA margin improving to 3.3% of NTV (vs 1.6% a year ago). International operations scaled 84% NTV growth and turned adjusted EBITDA positive for the full year. Native (water purifiers & smart locks) grew 67% NTV with losses narrowing sharply. The key investment drag is Insta Health, which posted ₹119 crore adjusted EBITDA loss as management prioritizes market leadership over near-term profitability. Consolidated adjusted EBITDA breakeven is reaffirmed by Q3 FY28, with a target of ₹1,000 crore adjusted EBITDA by FY31. Risk: competitive irrationality in Insta Health could pressure losses longer than anticipated.

Risks4 trackedTranscriptfull text

Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Insta Health competitive irrationality

View Risks →

≡Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Consolidated NTV ₹1,148 Cr

+42% YoY

Highest ever consolidated NTV growth in 15 quarters; crossed 10 million orders in a single quarter.

India Core NTV Growth 26%

+26% YoY

Fastest growth in 11 quarters for India consumer services ex-Insta Health.

International NTV Growth 84%

+84% YoY

UAE and Singapore businesses delivered 84% NTV growth in Q4 to ₹211 crore.

Insta Health Orders (March) 1.1M+

N/A

Insta Health delivered 2.7 million orders in Q4, with over 1.1 million in March alone.

Fast read

Guidance and risk preview

Top guidance Consolidated adjusted EBITDA breakeven by Q3 FY28

Management reaffirmed target of achieving consolidated adjusted EBITDA breakeven by Q3 FY28.

Top risk Insta Health competitive irrationality

Competitors raising funds and potentially engaging in irrational pricing or subsidies could pressure Insta Health's loss trajectory.